Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | TOP1 | P11387 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycerin SCHEMBL5729048 | 1.00 | PDE4A (0.56) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL27398 | 0.93 | PDE4A (0.62) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL17931825 | 0.93 | PDE4A (0.62) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL16491025 | 0.93 | PDE4A (0.62) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL16968414 | 0.93 | PDE4A (0.62) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL671091 | 0.93 | PDE4A (0.62) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL9961490 | 0.93 | PDE4A (0.62) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL342905 | 0.93 | PDE4A (0.62) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL13998184 | 0.93 | PDE4A (0.62) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL30497482 | 0.93 | PDE4A (0.62) | PDE4ALMNAL3MBTL1TDP1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200405797-A1 | TRANSMUCOSAL DELIVERY DEVICE AND METHOD OF MANUFACTURING SAME | NANOSTRIPS, INC. (US) | 2020-12-31 | — | — | US | claimed |
| US-20050238605-A1 | Low-viscosity O/W emulsion | BEIERSDORF AG | 2005-10-27 | — | — | US | claimed |
| EP-0932386-B1 | COSMETIC AND SKIN CARE STICKS WITH HIGH WATER CONTENTS | BEIERSDORF AG (DE) | 2004-09-08 | — | — | EP | claimed |
| CN-118354749-A | Kit and method for treating skin | 莱雅公司 | 2024-07-16 | — | — | CN | disclosed |
| CN-118201589-A | Cosmetic composition comprising a high amount of ceramide-NP | 莱雅公司 | 2024-06-14 | — | — | CN | disclosed |
| CN-114599345-A | Hair styling preparation | 拜尔斯道夫股份有限公司 | 2022-06-07 | — | — | CN | disclosed |
| US-20200405797-A1 | TRANSMUCOSAL DELIVERY DEVICE AND METHOD OF MANUFACTURING SAME | NANOSTRIPS, INC. (US) | 2020-12-31 | — | — | US | disclosed |
| US-7381423-B2 | Use of nanodispersions in cosmetic end formulations | CIBA SPECIALTY CHEMICALS CORP. (US) | 2008-06-03 | — | — | US | disclosed |
| US-7008638-B2 | Use of nanodispersions in cosmetic end formulations | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2006-03-07 | — | — | US | disclosed |
| US-20050238605-A1 | Low-viscosity O/W emulsion | BEIERSDORF AG | 2005-10-27 | — | — | US | disclosed |
| US-20050238605-A1 | Low-viscosity O/W emulsion | BEIERSDORF AG | 2005-10-27 | — | — | US | disclosed |
| US-20050191330-A1 | Easily prepared carrier systems for wide range of active agents and oil soluble dyes; homogeneous ethanol and water clear liquid containing phospholipid, endcapped polyoxyethylene coemulsifier and lipophilic triglyceride; wide pH range | CIBA SPECIALTY CHEMICALS CORP. | 2005-09-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050191330-A1 | Easily prepared carrier systems for wide range of active agents and oil soluble dyes; homogeneous ethanol and water clear liquid containing phospholipid, endcapped polyoxyethylene coemulsifier and lipophilic triglyceride; wide pH range | LIPA, CETP, LIPC | PDE4A 2968/4885LMNA 687/4885L3MBTL1 3220/4885 |
| US-20050238605-A1 | Low-viscosity O/W emulsion | POLH, DGAT2, POLQ | PDE4A 2596/4885LMNA 3912/4885L3MBTL1 2823/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.